[HTML][HTML] Comorbilidades y gravedad clínica de la COVID-19: revisión sistemática y meta-análisis
TM Plasencia-Urizarri, R Aguilera-Rodríguez… - Revista Habanera de …, 2020 - scielo.sld.cu
Objetivo: Evaluar el riesgo de COVID-19 con presentación clínica grave en pacientes con
comorbilidades. Material y métodos: Se realizó una revisión sistemática y meta-análisis en …
comorbilidades. Material y métodos: Se realizó una revisión sistemática y meta-análisis en …
[HTML][HTML] Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study
Y Cen, X Chen, Y Shen, XH Zhang, Y Lei, C Xu… - Clinical Microbiology …, 2020 - Elsevier
Abstract Objectives Since December 2019, the novel coronavirus disease 2019 (COVID-19)
that emerged in Wuhan city has spread rapidly around the world. The risk for poor outcome …
that emerged in Wuhan city has spread rapidly around the world. The risk for poor outcome …
[HTML][HTML] A comprehensive review of COVID-19 characteristics
H Esakandari, M Nabi-Afjadi, J Fakkari-Afjadi… - Biological procedures …, 2020 - Springer
In December 2019, a novel coronavirus, named Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) or (2019-nCoV) with unknown origin spread in Hubei province …
Coronavirus 2 (SARS-CoV-2) or (2019-nCoV) with unknown origin spread in Hubei province …
[HTML][HTML] COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality
Diabetes is a condition that affects a large percentage of the population and it is the leading
cause of a wide range of costly complications. Diabetes is linked to a multi-fold increase in …
cause of a wide range of costly complications. Diabetes is linked to a multi-fold increase in …
A hypothesis for pathobiology and treatment of COVID‐19: the centrality of ACE1/ACE2 imbalance
K Sriram, PA Insel - British journal of pharmacology, 2020 - Wiley Online Library
Angiotensin Converting Enzyme2 is the cell surface binding site for the coronavirus SARS‐
CoV‐2, which causes COVID‐19. We propose that an imbalance in the action of ACE1‐and …
CoV‐2, which causes COVID‐19. We propose that an imbalance in the action of ACE1‐and …
SARS-CoV-2, ACE2 expression, and systemic organ invasion
UM Ashraf, AA Abokor, JM Edwards… - Physiological …, 2021 - journals.physiology.org
A novel coronavirus disease, COVID-19, has created a global pandemic in 2020, posing an
enormous challenge to healthcare systems and affected communities. COVID-19 is caused …
enormous challenge to healthcare systems and affected communities. COVID-19 is caused …
[HTML][HTML] Coronavirus disease 2019 (COVID-19) outbreak: some serious consequences with urban and rural water cycle
The COVID-19 outbreak due to SARS-CoV-2 has raised several concerns for its high
transmission rate and unavailability of any treatment to date. Although major routes of its …
transmission rate and unavailability of any treatment to date. Although major routes of its …
[HTML][HTML] The ACE-2 in COVID-19: foe or friend?
COVID-19 is a rapidly spreading outbreak globally. Emerging evidence demonstrates that
older individuals and people with underlying metabolic conditions of diabetes mellitus …
older individuals and people with underlying metabolic conditions of diabetes mellitus …
[HTML][HTML] COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis
Background: The rapidly evolving coronavirus disease 2019 (COVID-19), was declared a
pandemic by the World Health Organization on March 11, 2020. It was first detected in the …
pandemic by the World Health Organization on March 11, 2020. It was first detected in the …
[HTML][HTML] Smoking and COVID-19: What we know so far
The ongoing COVID-19 pandemic has placed a spotlight on infectious diseases and their
associations with host factors and underlying conditions. New data on the Severe Acute …
associations with host factors and underlying conditions. New data on the Severe Acute …